Search - tctmd.com

Displaying 341 - 360 of 372

Sort: Relevancy | Date

News Conference News TCT 2012

Meta-Analyses Show Improved Outcomes with DES vs. BMS

October 22, 2012

News Conference News TCT 2012

COURAGE, FAME: Revascularization More Effective Than OMT

October 22, 2012

Presentation TCT 2012

Incidence and Predictors of Definite Stent Thrombosis After Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction in ‘Real World’ Patients

Presenter: Ivan Gomez, Victor Jimenez, Jose A. Baz, Guillermo Bastos, Antonio de Miguel, Alberto Ortiz, Andres I?iguez

January 03, 2012

Presentation TCT 2012

Everolimus-eluting stents show no stent thrombosis with similar one year outcomes compared with 1st and 2nd generation drug-eluting stents for the treatment of ST-segment...

Presenter: Kyounghoon Lee, Tae Hoon Ahn, Soon Yong Suh, Woong Chol Kang, Seung Hwan Han, Eak Kyun Shin

January 03, 2012

Presentation TCT 2012

Evaluation of second generation DES in an ex-vivo model of stent thrombosis

Presenter: Alexander Sheehy, Leigh B. Kleinert, Stephen Pacetti, Syed Hossainy, Mikael Trollsas, Stuart K. Williams

January 03, 2012

News Conference News

ROTAXUS: Rotablation Does Not Improve Stenting Results in Calcified Lesions

Yael L. Maxwell

November 30, 2011

News Conference News

TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year

L.A. McKeown

November 28, 2011

News Conference News

Stent Thrombosis Linked to Uncovered, Malapposed Stent Struts

November 21, 2011

News Conference News

Paclitaxel-Eluting Bioabsorbable Stent Shows Advantage over Bare-Metal Version

November 20, 2011

News Conference News

Two New SES Show Improvement Over First-Generation Stents

Yael L. Maxwell

November 10, 2011

News Conference News

EVOLVE: Bioabsorbable EES Noninferior to Permanent Polymer Version

November 10, 2011

News Conference News

RAPID GENE: Validation of Point-of-Care Genetic Testing

November 09, 2011

News Conference News

PARIS: Early DAPT Nonadherence, A Small Problem with Big Consequences

November 09, 2011

News Conference News

ADAPT-DES: Risk of Early Stent Thrombosis in DES Predicted by Platelet Inhibition

November 09, 2011

News Conference News

ZES and SES Equally Effective in Long Lesion Treatment

November 08, 2011

News Conference News

Safety, Efficacy Reported with FIREHAWK SES

November 08, 2011

News Conference News

Preclinical Results Promising for Combo Stent

November 08, 2011

News Conference News

Polymer-free DES Shown Effective in Multiple Trials

November 08, 2011

News Conference News

Ongoing Trials Explore Potential Benefits of Transradial PCI

November 08, 2011

News Conference News

Mock Jury Votes on DAPT Duration: 12 Months Remains Best Option for Most Patients

November 08, 2011

Advertisement

Meta-Analyses Show Improved Outcomes with DES vs. BMS

COURAGE, FAME: Revascularization More Effective Than OMT

Incidence and Predictors of Definite Stent Thrombosis After Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction in ‘Real World’ Patients

Everolimus-eluting stents show no stent thrombosis with similar one year outcomes compared with 1st and 2nd generation drug-eluting stents for the treatment of ST-segment...

Evaluation of second generation DES in an ex-vivo model of stent thrombosis

ROTAXUS: Rotablation Does Not Improve Stenting Results in Calcified Lesions

TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year

Stent Thrombosis Linked to Uncovered, Malapposed Stent Struts

Paclitaxel-Eluting Bioabsorbable Stent Shows Advantage over Bare-Metal Version

Two New SES Show Improvement Over First-Generation Stents

EVOLVE: Bioabsorbable EES Noninferior to Permanent Polymer Version

RAPID GENE: Validation of Point-of-Care Genetic Testing

PARIS: Early DAPT Nonadherence, A Small Problem with Big Consequences

ADAPT-DES: Risk of Early Stent Thrombosis in DES Predicted by Platelet Inhibition

ZES and SES Equally Effective in Long Lesion Treatment

Safety, Efficacy Reported with FIREHAWK SES

Preclinical Results Promising for Combo Stent

Polymer-free DES Shown Effective in Multiple Trials

Ongoing Trials Explore Potential Benefits of Transradial PCI

Mock Jury Votes on DAPT Duration: 12 Months Remains Best Option for Most Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content